Topical Anesthetics in Optometry: Proparacaine and Tetracaine

What Are Topical Ocular Anesthetics?

Topical ocular anesthetics are drops that temporarily numb the surface of the eye by blocking sensory nerve conduction in the cornea and conjunctiva. They work by inhibiting voltage-gated sodium channels in sensory nerve membranes. When sodium channels are blocked, nerve impulses cannot be generated, and the sensation of pain, pressure, and touch cannot reach the brain.

The onset is rapid (within 30 seconds to 1 minute) and the duration is brief (15 to 30 minutes), which is ideal for the short-duration procedures used in optometric practice. The two most commonly used agents are proparacaine and tetracaine.

Proparacaine

Proparacaine hydrochloride (available as 0.5%) is the most frequently used topical anesthetic in optometric offices. It is favored over tetracaine for routine use because it causes less initial stinging on instillation, making it more comfortable for patients. Onset occurs within about 30 seconds after a single drop, and anesthesia lasts approximately 10 to 20 minutes.

Proparacaine is stored refrigerated to maintain potency. Discolored or yellow-tinged solution should be discarded, as it indicates oxidation and reduced efficacy.

Tetracaine

Tetracaine hydrochloride (0.5%) produces deeper and longer-lasting anesthesia than proparacaine but causes more initial discomfort on instillation. It may be preferred when a slightly longer anesthetic window is needed, such as for more extended contact procedures.

Clinical Uses of Topical Anesthetics

Topical anesthetics are used across many common diagnostic and minor therapeutic procedures:

The Critical Rule: Never for Home Use

One of the most important clinical principles surrounding topical anesthetics is that they must never be prescribed for home use or sent home with a patient. This rule exists because:

• Anesthesia masks symptoms. If a patient with a corneal abrasion or infection self-applies anesthetic at home, they eliminate the pain that serves as a warning signal. They may ignore worsening pathology until it becomes vision-threatening.
• Anesthesia delays healing. Topical anesthetics inhibit epithelial cell migration, impair mitosis of corneal epithelial cells, and disrupt the normal healing response. Chronic application leads to epithelial breakdown, stromal haze, and ultimately corneal perforation.
• Anesthesia promotes infection. A numb cornea loses the blink reflex and tear film maintenance, making it vulnerable to bacterial invasion and ulceration.

Topical anesthetic misuse (self-application for pain control) is a known cause of neurotrophic keratopathy, a devastating corneal condition that can result in permanent scarring and vision loss.

Adverse Effects and Precautions

When used appropriately in-office, topical anesthetics are very safe. Known effects include:

• Transient stinging on instillation (more pronounced with tetracaine).
• Temporary epithelial irregularity after contact procedures (resolves quickly).
• Allergic reactions: Proparacaine is an ester-type anesthetic, and some patients may develop a true contact allergy, presenting as redness, swelling, and chemosis after repeat exposures.
• Systemic effects are rare with standard diagnostic doses but can include CNS or cardiovascular effects with excessive absorption.

Key Takeaways

• Topical anesthetics (proparacaine, tetracaine) block voltage-gated sodium channels, temporarily eliminating corneal and conjunctival sensation.
• Onset is within 30 seconds; duration is 15 to 30 minutes.
• Proparacaine is preferred for routine use because it is less irritating on instillation.
• Topical anesthetics must never be prescribed for patient home use because they mask symptoms, impair healing, and promote corneal infection.